Nicolas Pejovic's picture

Nicolas Pejovic

PhD Candidate, Senior Consultant in Neonatology
  • E-mailNicolas.Pejovic@uib.no
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen

Nicolas Pejovic did his medical training at Uppsala University and at UCSD, San Diego, USA. He completed his Medical Doctor qualification at Uppsala University and specialisations in Paediatrics and Neonatology in Stockholm. He works as a Senior Consultant in Neonatology, Sachs Children’s Hospital, Stockholm, and is affiliated as a researcher in Global Health at the Department of Public Health Sciences at Karolinska Institutet and the Centre for International Health in Bergen, Norway.

He has worked and done research in Sweden, Norway, Uganda, Burkina Faso and, Vietnam.

Nicolas research aims to reduce neonatal mortality and morbidity with research projects mostly in low-income-countries, like Uganda, Burkina Faso and, Viet Nam, but also in Sweden. His projects have focused on postnatal newborn collapse (SUPC), neonatal resuscitation in low-resource settings, laryngeal mask airway (LMA) in newborn, heart rate monitoring using MHealth platforms and training health staff in newborn resuscitation and essential  newborn care with the Helping Babies Breath (HBB)  curriculum. 

He is also the director of Tap4Life.org, a non-profit organization based in Stockholm. Its mission is to improve global neonatal health care by providing free mHealth applications for hospital staff both in high and low-resource countries.

Learn more about Nicolas' work: Saving newborns

Languages Swedish, native tongue – English/French, fluently spoken and written 

Nicolas is an instructor in patient simulation at the CEPS (Concept for Patient Simulation) at the South Hospital in Stockholm. He is also a HBB instructor and has trained over 500 midwives in Africa. He has also trained health staff for Médecins Sans Frontières (MSF).

  • Show author(s) 2020. Smartphone app for neonatal heart rate assessment: an observational study. BMJ Paediatrics Open.
  • Show author(s) 2020. Adding video-debriefing to Helping-Babies-Breathe training enhanced retention of neonatal resuscitation knowledge and skills among health workers in Uganda: a cluster randomized trial. Global health action.
  • Show author(s) 2020. A randomized trial of laryngeal mask airway in neonatal resuscitation. New England Journal of Medicine. 2138-2147.
  • Show author(s) 2019. Neonatal resuscitation using a supraglottic airway device for improved mortality and morbidity outcomes in a low-income country: Study protocol for a randomized trial. Trials. 1-9.
  • Show author(s) 2018. Heart rate assessment using NeoTapAdvancedSupport: A simulation study. Archives of Disease in Childhood: Fetal and Neonatal Edition.
  • Show author(s) 2018. Accurate and fast neonatal heart rate assessment with a smartphone‐based application – a manikin study. Acta Paediatrica. 1548-1554.
  • Show author(s) 2017. Neonatal resuscitation using a laryngeal mask airway: a randomised trial in Uganda. Archives of Disease in Childhood. 255-260.
  • Show author(s) 2017. NeoTapLS: a mHealth tool for assessing heart rate during neonatal resuscitation in low resource settings.
  • Show author(s) 2017. Kufflös larynxmask kan minska risker vid neonatal återupplivning. Läkartidningen.
  • Show author(s) 2017. Kufflös larynxmask kan minska risker vid neonatal återupplivning. Läkartidningen.
  • Show author(s) 2016. Pilot manikin study showed that a supraglottic airway device improved simulated neonatal ventilation in a low-resource setting. Acta Paediatrica. 1440-1443.
  • Show author(s) 2015. Laryngeal mask airway (LMA) vs. face-mask ventilation (FMV) in neonatal resuscitation in the hands of midwifes in Uganda: a randomized clinical trial.

More information in national current research information system (CRIStin)


Research projects


Co-investigator in the NEO-SPIRIT Trial (NEOnatal SuPRaglottic vIetnam Trial) 

Assessment of a Supraglottic Device Versus Endotracheal Intubation in Neonatal Resuscitation in Vietnam – a Randomised Phase III Clinical Trial (NEO-SPIRIT).


2016 – 2019

NeoSupra trial, a multi-centre, phase III, open-label, randomized clinical trial to evaluate the efficacy of i-gel®supraglottic airway used in neonatal resuscitation in reducing early neonatal mortality and morbidity compared to standard of care face-mask ventilation (FMV) in low income countries. Part of the coordination team, the steering committee and data management team.